Biodesix, Inc. BDSX Operating Lease Right Of Use Asset Reduction Accretion Amortization Expense
Other financials
Where this comes from
Reported directly by Biodesix, Inc. in its filing.
Tagged under the XBRL concept bdsx:OperatingLeaseRightOfUseAssetReductionAccretionAmortizationExpense.
The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Biodesix, Inc.'s operating lease right of use asset reduction accretion amortization expense.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Biodesix, Inc.'s operating lease right of use asset reduction accretion amortization expense?
- Biodesix, Inc. (BDSX) reported operating lease right of use asset reduction accretion amortization expense of $19K in Q1 2026.